期刊文献+

MCP-1、MMP-9、TIMP-1在川崎病中的表达及与冠状动脉病变的关系 被引量:5

Expressions of MCP-1,MMP-9,TIMP-1and their relationship with coronary artery lesions in children with Kawasaki disease
原文传递
导出
摘要 目的探讨单核细胞趋化蛋白1(MCP-1)、基质金属蛋白酶9(MMP-9)、金属蛋白酶特异性抑制剂1(TIMP-1)在川崎病(KD)患儿的表达及其与冠状动脉病变(CAL)的关系。方法 45例川崎病患儿分为有CAL(CAL组,15例)和无CAL(NCAL组,30例)两组,另外选取20例因呼吸道感染发热患儿(F组)和10例健康儿童(C组)为对照。采用ELISA检测血清MCP-1、MMP-9和TIMP-1水平,RT-PCR检测单核细胞中MCP-1、MMP-9和TIMP-1mRNA表达水平,心脏彩超观察CAL情况。结果CAL组和NCAL组急性期、缓解期血清MCP-1、MMP-9、TIMP-1、MMP-9/TIMP-1比值及外周血单核细胞中MCP-1、MMP-9、TIMP-1 mRNA表达水平均高于F、C组(P<0.01)。CAL组急性期血清MCP-1、MMP-9、TIMP-1、MMP-9/TIMP-1比值及MCP-1、MMP-9、TIMP-1mRNA表达水平均高于NCAL组(P<0.01或P<0.05),KD患儿血清MMP-9/TIMP-l比值与左冠状动脉内径/主动脉瓣环内径比值呈正相关(r=0.502,P<0.05)。结论联合检测MCP-1和MMP-9有助于预测和早期诊断KD患儿的CAL。 Objective To explore the expressions of monocyte chemotactic protein 1(MCP-1),matrix metalloproteinase 9(MMP-9),tissue inhibitor of metalloproteinases 1(TIMP-1)and their relationship with coronary artery lesions(CAL)in the children with Kawasaki disease(KD).Methods A total of 45 children with KD was divided into groups of CAL(KD with CAL,15cases)and NCAL(KD without CAL,30cases).Twenty children with fever due to respiratory tract infection(group F)and 10 healthy children(group C)were taken as the controls.Serum levels of MCP-1,MMP-9and TIMP-1were detected by ELISA and MCP-1,MMP-9and TIMP-1 mRNA in mononuclear cells of peripheral blood were detected by RT-PCR.CAL was observed by echocardiography.The ratio of MMP-9to TIMP-1 was calculated.Results Serum levels of MCP-1,MMP-9 and TIMP-1,and MMP-9/TIMP-1ratio and the expressions of MCP-1,MMP-9and TIMP-1 mRNA in mononuclear cells of peripheral blood were all significantly higher in groups of CAL and NCAL in acute and remission stages than those in groups of F and C(P〈0.01),which were higher in KD children in acute stage than those in remission stage(P〈0.01 or P〈0.05).The MMP-9/TIMP-1ratio was positively correlated to the ratio of diameter of the left coronary artery to inner diameter of the aortic valve ring(r=0.502,P〈0.05).Conclusion Combined detection of MCP-1and MMP-9is helpful in the prediction and early diagnosis of CAL in KD children.
出处 《江苏医药》 CAS 北大核心 2014年第21期2551-2554,共4页 Jiangsu Medical Journal
基金 江苏省卫生厅面上科研项目(HS201423) 南通市社会事业科技创新与示范计划(HS2012048)
关键词 川崎病 单核细胞趋化蛋白1 基质金属蛋白酶9 金属蛋白酶特异性抑制剂1 Kawasaki disease Monocyte chemotactic protein 1 Matrix metalloproteinase 9 Tissue inhibitor of metalloproteinases 1
  • 相关文献

参考文献10

  • 1Nakamura Y,Yashiro M,Uehara R,et al.Epidemiologic features of Kawasaki disease in Japan:results of the 2007-2008nationwide survey[J].J Epidemiol,2010,20(4):302-307.
  • 2Gordon JB,Kahn AM,Burns JC.When children with Kawasaki disease grow up:myocardial and vascular complications in adulthood[J].J Am Coll Cardiol,2009,54(21):1911-1920.
  • 3Japaness Circulation Society Joint Research Group.Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J].Pediatr Int,2005,47(6):711-732.
  • 4Belay ED,Maddox RA,Holman RC,et al.Kawasaki syndrome and risk factors for coronary artery abnormalities:United States,1994-2003[J].Pediatr Infect Dis J,2006,25(3):245-249.
  • 5黄国英,吴瑶.川崎病冠状动脉病变的危险分层与处理对策[J].临床儿科杂志,2010,28(7):611-613. 被引量:14
  • 6Lin IC,Suen JL,Huang SK,et al.Dectin-1/Syk signaling is involved in Lactobacillus casei cell wall extract-induced mouse model of Kawasaki disease[J].Immunobiology,2013,218(2):201-212.
  • 7Yin W,Wang X,Ding Y,et al.Expression of nuclear factor-κB p65in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions[J].Indian J Pediatr,2011,78(11):1378-1382.
  • 8Inoue N,Takai S,Jin D,et al.Effect of angiotensin-converting enzyme inhibitor on matrix metalloproteinase-9activity in patients with Kawasaki disease[J].Clin Chim Acta,2010,411(3-4):267-269.
  • 9Lau AC,Duong TT,Ito S,et al.Inhibition of matrix metalloproteinase-9activity improves coronary outcome in an animal model of Kawasaki disease[J].Clin Exp Immunol,2009,157(2):300-309.
  • 10Korematsu S,Ohta Y,Tamai N,et al.Cell distribution differences of matrix metalloproteinase-9and tissue inhibitor of matrix metalloproteinase-1in patients with Kawasaki disease[J].Pediatr Infect Dis J,2012,31(9):973-974.

二级参考文献8

  • 1De Zorzi A,Colan SD,Gauvreau K,et al.Coronary artery dimensions may be misclassified as normal in Kawasaki disease[J].J Pediatr,1998,133(2):254-258.
  • 2黄国英.冠状动脉并发症的诊断[M] //杜忠东.川崎病.北京:科学技术文献出版社,2009:131-135.
  • 3Belay ED,Maddox RA,Holman RC,et al.Kawasaki syndrome and risk factors for coronary artery abnormalities:United States,1994-2003[J].Pediatr Infect Dis J,2006,25(3):245-249.
  • 4Japanese Circulation Society Joint Research Group.Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J].Pediatr Int,2005,47(6):711-714.
  • 5Satou GM,Giamelli J,Gewitz MH,et al.Kawasaki disease:diagnosis,management,and long-term implications[J].Cardiol Rev,2007,15(4):163-169.
  • 6Tsuda E,Kamiya T,Ono Y,et al.Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diamete during Kawasaki disease[J].Pediatr Cardiol,2005,26(1):73-79.
  • 7Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the committee on rheumatic fever,endocarditis,and Kawasaki disease,council on cardiovascular disease in the young,American Heart Association[J].Pediatrics,2004,114(6):1708-1733.
  • 8黄国英.充分认识川崎病患儿的心血管损害[J].国际儿科学杂志,2008,35(3):197-198. 被引量:4

共引文献13

同被引文献51

  • 1汪雁归,刘昭前,杨天(山仑).急性冠脉综合征患者血清MCP-1浓度和CCR2蛋白表达水平的变化[J].中南大学学报(医学版),2009,34(4):318-322. 被引量:5
  • 2魏莉,徐盈.基质金属蛋白酶9在老年肺癌中的表达及临床意义[J].中国老年学杂志,2014,34(1):89-90. 被引量:8
  • 3胡亚美,江载芳,申昆玲,等.诸福棠实用儿科学[M].8版.北京:人民卫生出版社,2015:916-919.
  • 4Korematsu S,Ohta Y,Tamai N,et al.Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1in patients with Kawasaki disease[J].Pediatr Infect Dis J,2012,31(9):973-974.
  • 5Oharaseki T,Yokouchi Y,Yamada H,et al.The role of TNF-αin a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide[J].Mod Rheumatol,2014,24(1):120-128.
  • 6Lau AC,Duong TT,Ito S,et al.Inhibition of matrix metalloproteinase-9activity improves coronary outcome in an animal model of Kawasaki disease[J].Clin Exp immunol,2009,157(2):300-309.
  • 7Dimitriades V R,Brown A G,Gedalia A.Kawasaki disease:pathophysiology,clinical manifestations and management[J].Curr Rheumatol Rep,2014,16(6):423-426.
  • 8Kumar R K,Tandon R.Rheumatic fever&:rheumatic heart disease:the last 50 years[J].Indian J Med Res,2013,137(4):643-658.
  • 9Korematsu S,Ohta Y,Tamai N,et al.Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with Kawasaki disease[J].Pediatr Infect Dis J,2012,31(9):973-974.
  • 10Visse R,Hideaki N.Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure,function,and biochemistry[J].Circ Res,2003,92(8):827-839.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部